Cancer

Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in...

SimBioSys and Ricoh 3D for Healthcare announce strategic alliance expanding access to TumorSight™ Viz for breast cancer surgery

Commercial partnership expected to accelerate adoption of SimBioSys' AI-powered surgical visualization platform following recent FDA clearance of TumorSight Viz 1.3 ...

NextGen Healthcare Achieves HTI-1 Compliance for NextGen® Enterprise EHR, Meeting Latest AI, Data and Interoperability Standards

Healthtech Company Leads the Way Ahead of ONC’s December 31 Compliance DeadlineREMOTE-FIRST COMPANY/WASHINGTON--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, a leading provider of innovative,...

MAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal Cells

CHICAGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company...

Fresenius Leads New EASYGEN Consortium Aimed at Decentralizing CAR-T Cell Therapy and Improving Hospital Workflows

Physicians, researchers, and partner institutions across Europe aim to deliver innovative, personalized therapies more quickly Development project focused on a...

Astrin Biosciences Appoints MIT Cancer Researcher Dr. Forest White as Distinguished Scientist to Advance Application of Proteomics for Early Cancer Detection

ST. PAUL, Minn., Aug. 26, 2025 /PRNewswire/ -- Today, Astrin Biosciences, the cancer intelligence company transforming detection and treatment via...

error: Content is protected !!